-
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count.
Endocrine ReviewsSo M, Speake C, Steck AK, Lundgren M, Colman PG, Palmer JP, Herold KC, Greenbaum CJ -
In Vivo Expansion of Antigen-Specific Regulatory T Cells through Staggered Fc.IL-2 Mutein Dosing and Antigen-Specific Immunotherapy.
ImmunohorizonsPham MN, Khoryati L, Jamison BL, Hayes E, Sullivan JM, Campbell DJ, Gavin MA -
High-throughput single-cell quantification of hundreds of proteins using conventional flow cytometry and machine learning.
Science AdvancesBecht E, Tolstrup D, Dutertre CA, Morawski PA, Campbell DJ, Ginhoux F, Newell EW, Gottardo R, Headley MB -
Approaches to Establishing Tolerance in Immune Mediated Diseases.
Frontiers in ImmunologyHuffaker MF, Sanda S, Chandran S, Chung SA, St Clair EW, Nepom GT, Smilek DE -
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA.
Arthritis Research & TherapyRigby W, Buckner JH, Louis Bridges S Jr, Nys M, Gao S, Polinsky M, Ray N, Bykerk V -
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.
PLoS PathogensHeide J, Schulte S, Kohsar M, Brehm TT, Herrmann M, Karsten H, Marget M, Peine S, Johansson AM, Sette A, Lütgehetmann M, Kwok WW, Sidney J, Schulze Zur Wiesch J -
Evaluating associations of joint swelling, joint stiffness and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA), a prospective cohort study.
BMJ OpenHughes-Austin JM, Ix JH, Ward SR, Weisman MH, ODell JR, Mikuls TR, Buckner JH, Gregersen PK, Keating RM, Demoruelle MK, Deane KD, Holers VM, Norris JM -
PGD2 and CRTH2 counteract Type 2 cytokine-elicited intestinal epithelial responses during helminth infection.
The Journal of Experimental MedicineOyesola OO, Shanahan MT, Kanke M, Mooney BM, Webb LM, Smita S, Matheson MK, Campioli P, Pham D, Früh SP, McGinty JW, Churchill MJ, Cahoon JL, Sundaravaradan P, Flitter BA, Mouli K, Nadjsombati MS, Kamynina E, Peng SA, Cubitt RL, Gronert K, Lord JD, Rauch I, von Moltke J, Sethupathy P, Tait Wojno ED -
Optimal human pathogenic TH2 cell effector function requires local epithelial cytokine signaling.
The Journal of Allergy and Clinical ImmunologyCalise J, Garabatos N, Bajzik V, Farrington M, Robinson D, Jeong D, Londei M, Wambre E -
The parasite cytokine mimic Hp-TGM potently replicates the regulatory effects of TGF-β on murine CD4+ T cells.
Immunology and Cell BiologyWhite MPJ, Smyth DJ, Cook L, Ziegler SF, Levings MK, Maizels RM -
Induction of stable human FOXP3+ Tregs by a parasite-derived TGF-β mimic.
Immunology and Cell BiologyCook L, Reid KT, Häkkinen E, de Bie B, Tanaka S, Smyth DJ, White MP, Wong MQ, Huang Q, Gillies JK, Ziegler SF, Maizels RM, Levings MK -
Overview of oral tolerance induction for prevention of food allergy-Where are we now?
AllergyKrawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G -
Evolution of epitope-specific IgE and IgG4 antibodies in children enrolled in the LEAP trial.
The Journal of Allergy and Clinical ImmunologySuarez-Farinas M, Suprun M, Bahnson HT, Raghunathan R, Getts R, duToit G, Lack G, Sampson HA -
Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march.
Annals of Allergy, Asthma & ImmunologyZiegler SF -
Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer.
Frontiers in OncologyHirani P, Gauthier V, Allen CE, Wight TN, Pearce OMT
